Status:
TERMINATED
REassessement After Hospitalization for Sars-COV-2 disordER
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Sars-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
Currently, the sequelae and short-term medical and psychological impact of the sars-cov-2 infection ("CoVID-19") remain poorly described. The clinical and functional sequelae that may persist after ac...
Detailed Description
Since sars-cov-2 ("CoVID-19") is a newly defined infection, its sequelae and short-term medical and psychological impact remain poorly described.The clinical and functional sequelae that may persist a...
Eligibility Criteria
Inclusion
- patient who was hospitalized within 3 to 6 months for a sars-CoV infection
Exclusion
- Absence of signed informed consent
- pregnancy or breastfeeding
- patient under guardianship or curatorship
Key Trial Info
Start Date :
July 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2022
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT04443257
Start Date
July 8 2020
End Date
February 18 2022
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Montpellier
Montpellier, France, 34295